HIV-1 Tat protein binds to TLR4-MD2 and signals to induce TNF-α and IL-10

Retrovirology

Volumn 10, Issue 1, 2013, Pages

  Ben Haij, Nawal ^a,b   Leghmari, Kaoutar ^a,b   Planès, Rémi ^a,b   Thieblemont, Nathalie ^c   Bahraoui, Elmostafa ^a,b  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b CHU PURPAN   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

HIV 1; IL 10; Tat; TLR4; TNF

Indexed keywords

CD14 ANTIGEN; INTERLEUKIN 10; PROTEIN MD 2; TOLL LIKE RECEPTOR 4; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE DYSREGULATION; IN VIVO STUDY; MONOCYTE MACROPHAGE PRECURSOR CELL; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CELLS, CULTURED; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERLEUKIN-10; LYMPHOCYTE ANTIGEN 96; MONOCYTES; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84890115621     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-10-123     Document Type: Article

References (51)

1. Uchil PD, Mothes W. HIV entry revisited. Cell 2009, 137(3):402-4. 10.1016/j.cell.2009.04.033, 2803685, 19410537.
2. Brenchley JM, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006, 12(12):1365-71.
3. Boasso A, Shearer GM. Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. Clin Immunol 2008, 126(3):235-42. 10.1016/j.clim.2007.08.015, 2275778, 17916442.
4. Mir KD, et al. Simian immunodeficiency virus-induced alterations in monocyte production of tumor necrosis factor alpha contribute to reduced immune activation in sooty mangabeys. J Virol 2012, 86(14):7605-15. 10.1128/JVI.06813-11, 3416282, 22553338.
5. Clerici M, et al. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest 1994, 93(2):768-75. 10.1172/JCI117031, 293925, 8113410.
6. Lepelley A, et al. Innate sensing of HIV-infected cells. PLoS Pathog 2011, 7(2):e1001284. 10.1371/journal.ppat.1001284, 3040675, 21379343.
7. Schmidt B, et al. HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration. Virology 2005, 343(2):256-66. 10.1016/j.virol.2005.09.059, 16278001.
8. Breckpot K, et al. HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7. J Virol 2010, 84(11):5627-36. 10.1128/JVI.00014-10, 2876620, 20237085.
9. Ishii KJ, et al. Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 2008, 3(6):352-63. 10.1016/j.chom.2008.05.003, 18541212.
10. Leghmari K, Bennasser Y, Bahraoui E. HIV-1 Tat protein induces IL-10 production in monocytes by classical and alternative NF-kappaB pathways. Eur J Cell Biol 2008, 87(12):947-62. 10.1016/j.ejcb.2008.06.005, 18760861.
11. Badou A, et al. Tat protein of human immunodeficiency virus type 1 induces interleukin-10 in human peripheral blood monocytes: implication of protein kinase C-dependent pathway. J Virol 2000, 74(22):10551-62. 10.1128/JVI.74.22.10551-10562.2000, 110929, 11044099.
12. Bennasser Y, Bahraoui E. HIV-1 Tat protein induces interleukin-10 in human peripheral blood monocytes: involvement of protein kinase C-betaII and -delta. Faseb J 2002, 16(6):546-54. 10.1096/fj.01-0775com, 11919157.
13. Contreras X, Bennasser Y, Bahraoui E. IL-10 production induced by HIV-1 Tat stimulation of human monocytes is dependent on the activation of PKC beta(II) and delta isozymes. Microbes Infect 2004, 6(13):1182-90. 10.1016/j.micinf.2004.06.008, 15488737.
14. Lotz M, Clark-Lewis I, Ganu V. HIV-1 transactivator protein Tat induces proliferation and TGF beta expression in human articular chondrocytes. J Cell Biol 1994, 124(3):365-71. 10.1083/jcb.124.3.365, 2119928, 8294518.
15. Zauli G, et al. Tat protein stimulates production of transforming growth factor-beta 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood 1992, 80(12):3036-43.
16. Frankel AD. Activation of HIV transcription by Tat. Curr Opin Genet Dev 1992, 2(2):293-8. 10.1016/S0959-437X(05)80287-4, 1638124.
17. Feng S, Holland EC. HIV-1 tat trans-activation requires the loop sequence within tar. Nature 1988, 334(6178):165-7. 10.1038/334165a0, 3386755.
18. Goldstein G. HIV-1 Tat protein as a potential AIDS vaccine. Nat Med 1996, 2(9):960-4. 10.1038/nm0996-960, 8782444.
19. Westendorp MO, et al. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 1995, 375(6531):497-500. 10.1038/375497a0, 7539892.
20. Xiao H, et al. Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc Natl Acad Sci USA 2000, 97(21):11466-71. 10.1073/pnas.97.21.11466, 17223, 11027346.
21. Urbinati C, et al. HIV-1 Tat and heparan sulfate proteoglycan interaction: a novel mechanism of lymphocyte adhesion and migration across the endothelium. Blood 2009, 114(15):3335-42. 10.1182/blood-2009-01-198945, 19661268.
22. Ensoli B, et al. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 1993, 67(1):277-87. 237361, 8416373.
23. Howcroft TK, et al. Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science 1993, 260(5112):1320-2. 10.1126/science.8493575, 8493575.
24. Kim TA, et al. HIV-1 Tat-mediated apoptosis in human brain microvascular endothelial cells. J Immunol 2003, 170(5):2629-37.
25. Sabatier JM, et al. Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J Virol 1991, 65(2):961-7. 239839, 1898974.
26. Li CJ, et al. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 1995, 268(5209):429-31. 10.1126/science.7716549, 7716549.
27. Canani RB, et al. Inhibitory effect of HIV-1 Tat protein on the sodium-D-glucose symporter of human intestinal epithelial cells. Aids 2006, 20(1):5-10. 10.1097/01.aids.0000198088.85572.68, 16327313.
28. Gutheil WG, et al. Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity. Proc Natl Acad Sci USA 1994, 91(14):6594-8. 10.1073/pnas.91.14.6594, 44249, 7912830.
29. Contreras X, et al. Human immunodeficiency virus type 1 Tat protein induces an intracellular calcium increase in human monocytes that requires DHP receptors: involvement in TNF-alpha production. Virology 2005, 332(1):316-28. 10.1016/j.virol.2004.11.032, 15661163.
30. Rubartelli A, et al. HIV-I Tat: a polypeptide for all seasons. Immunol Today 1998, 19(12):543-5. 10.1016/S0167-5699(98)01351-6, 9864943.
31. Albini A, et al. HIV-tat protein is a heparin-binding angiogenic growth factor. Oncogene 1996, 12(2):289-97.
32. Akira S. TLR signaling. Curr Top Microbiol Immunol 2006, 311:1-16.
33. Coats SR, et al. MD-2 mediates the ability of tetra-acylated and penta-acylated lipopolysaccharides to antagonize Escherichia coli lipopolysaccharide at the TLR4 signaling complex. J Immunol 2005, 175(7):4490-8.
34. Lee CC, Avalos AM, Ploegh HL. Accessory molecules for Toll-like receptors and their function. Nat Rev Immunol 2012, 12(3):168-79. 3677579, 22301850.
35. Debaisieux S, et al. The ins and outs of HIV-1 Tat. Traffic 2012, 13(3):355-63. 10.1111/j.1600-0854.2011.01286.x, 21951552.
36. Shin HJ, et al. Kinetics of binding of LPS to recombinant CD14, TLR4, and MD-2 proteins. Mol Cells 2007, 24(1):119-24.
37. Kirkland TN, et al. Analysis of lipopolysaccharide binding by CD14. J Biol Chem 1993, 268(33):24818-23.
38. Thomas CJ, et al. Evidence of a trimolecular complex involving LPS, LPS binding protein and soluble CD14 as an effector of LPS response. FEBS Lett 2002, 531(2):184-8. 10.1016/S0014-5793(02)03499-3, 12417309.
39. Nagai Y, et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 2002, 3(7):667-72.
40. Kurt-Jones EA, et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000, 1(5):398-401. 10.1038/80833, 11062499.
41. Murawski MR, et al. Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J Virol 2009, 83(3):1492-500. 10.1128/JVI.00671-08, 2620898, 19019963.
42. Haynes LM, et al. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol 2001, 75(22):10730-7. 10.1128/JVI.75.22.10730-10737.2001, 114654, 11602714.
43. Rassa JC, et al. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Natl Acad Sci USA 2002, 99(4):2281-6. 10.1073/pnas.042355399, 122356, 11854525.
44. Boehme KW, Compton T. Innate sensing of viruses by toll-like receptors. J Virol 2004, 78(15):7867-73. 10.1128/JVI.78.15.7867-7873.2004, 446107, 15254159.
45. Said EA, et al. Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat Med 2010, 16(4):452-459. 10.1038/nm.2106, 20208540.
46. Favre D, et al. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl Med 2010, 2(32):32ra36. 3034445, 20484731.
47. Weissman D, Poli G, Fauci AS. IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 9(5):442-9.
48. Finnegan A, et al. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage. J Immunol 1996, 156(2):841-51.
49. Lysakova-Devine T, et al. Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule. J Immunol 2010, 185(7):4261-71. 10.4049/jimmunol.1002013, 20802145.
50. Abe T, et al. Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines. J Virol 2007, 81(17):8953-66. 10.1128/JVI.00649-07, 1951400, 17567694.
51. Grela F, et al. The TLR7 agonist R848 alleviates allergic inflammation by targeting invariant NKT cells to produce IFN-gamma. J Immunol 2011, 186(1):284-90. 10.4049/jimmunol.1001348, 21131420.